Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S.
Ahmed MIM, Plank M, Castelletti N, Diepers P, Eser TM, Rubio-Acero R, Noreña I, Reinkemeyer C, Zapf D, Hoelscher M, Janke C, Wieser A, Geldmacher C, On Behalf Of The KoCo/Orchestra Study Group. Ahmed MIM, et al. Among authors: rubio acero r. Diagnostics (Basel). 2023 Mar 8;13(6):1024. doi: 10.3390/diagnostics13061024. Diagnostics (Basel). 2023. PMID: 36980332 Free PMC article.
Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity.
Merkt S, Ali S, Gudina EK, Adissu W, Gize A, Muenchhoff M, Graf A, Krebs S, Elsbernd K, Kisch R, Betizazu SS, Fantahun B, Bekele D, Rubio-Acero R, Gashaw M, Girma E, Yilma D, Zeynudin A, Paunovic I, Hoelscher M, Blum H, Hasenauer J, Kroidl A, Wieser A. Merkt S, et al. Among authors: rubio acero r. Nat Commun. 2024 Apr 24;15(1):3463. doi: 10.1038/s41467-024-47556-2. Nat Commun. 2024. PMID: 38658564 Free PMC article.
A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.
Beyerl J, Rubio-Acero R, Castelletti N, Paunovic I, Kroidl I, Khan ZN, Bakuli A, Tautz A, Oft J, Hoelscher M, Wieser A; KoCo19 Study group (members listed in the supplementary material). Beyerl J, et al. EBioMedicine. 2021 Aug;70:103502. doi: 10.1016/j.ebiom.2021.103502. Epub 2021 Jul 29. EBioMedicine. 2021. PMID: 34333234 Free PMC article.
Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.
Fryatt A, Simms V, Bandason T, Redzo N, Olaru ID, Ndhlovu CE, Mujuru H, Rusakaniko S, Hoelscher M, Rubio-Acero R, Paunovic I, Wieser A, Chonzi P, Masunda K, Ferrand RA, Kranzer K. Fryatt A, et al. EClinicalMedicine. 2021 Nov;41:101172. doi: 10.1016/j.eclinm.2021.101172. Epub 2021 Oct 24. EClinicalMedicine. 2021. PMID: 34723165 Free PMC article.
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections.
Ahmed MIM, Diepers P, Janke C, Plank M, Eser TM, Rubio-Acero R, Fuchs A, Baranov O, Castelletti N, Kroidl I, Olbrich L, Bauer B, Wang D, Prelog M, Liese JG, Reinkemeyer C, Hoelscher M, Steininger P, Überla K, Wieser A, Geldmacher C. Ahmed MIM, et al. Among authors: rubio acero r. Front Immunol. 2022 Dec 13;13:1026473. doi: 10.3389/fimmu.2022.1026473. eCollection 2022. Front Immunol. 2022. PMID: 36582222 Free PMC article.
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system.
Castelletti N, Paunovic I, Rubio-Acero R, Beyerl J, Plank M, Reinkemeyer C, Kroidl I, Noreña I, Winter S, Olbrich L, Janke C, Hoelscher M, Wieser A; KoCo19/ORCHESTRA Working group. Castelletti N, et al. Among authors: rubio acero r. Microbiol Spectr. 2024 Apr 2;12(4):e0288523. doi: 10.1128/spectrum.02885-23. Epub 2024 Mar 1. Microbiol Spectr. 2024. PMID: 38426747 Free PMC article.
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Brand I, Gilberg L, Bruger J, Garí M, Wieser A, Eser TM, Frese J, Ahmed MIM, Rubio-Acero R, Guggenbuehl Noller JM, Castelletti N, Diekmannshemke J, Thiesbrummel S, Huynh D, Winter S, Kroidl I, Fuchs C, Hoelscher M, Roider J, Kobold S, Pritsch M, Geldmacher C. Brand I, et al. Front Immunol. 2021 May 20;12:688436. doi: 10.3389/fimmu.2021.688436. eCollection 2021. Front Immunol. 2021. PMID: 34093595 Free PMC article.
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.
Kroidl I, Winter S, Rubio-Acero R, Bakuli A, Geldmacher C, Eser TM, Déak F, Horn S, Zielke A, Ahmed MIM, Diepers P, Guggenbühl J, Frese J, Bruger J, Puchinger K, Reich J, Falk P, Markgraf A, Fensterseifer H, Paunovic I, Thomschke A, Pritsch M, Riess F, Saathoff E, Hoelscher M, Olbrich L, Castelletti N, Wieser A; KoCo19/ORCHESTRA Study Group. Kroidl I, et al. Among authors: rubio acero r. Virol J. 2023 Sep 1;20(1):200. doi: 10.1186/s12985-023-02167-z. Virol J. 2023. PMID: 37658454 Free PMC article.
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.
Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, Mueller-Schmucker SM, Beileke S, Goekkaya M, Kling E, Geldmacher C, Rubio-Acero R, Plank M, Christa C, Willmann A, Vu M, Einhauser S, Weps M, Lampl BMJ, Almanzar G, Kousha K, Schwägerl V, Liebl B, Weber B, Drescher J, Scheidt J, Gefeller O, Messmann H, Protzer U, Liese J, Hoelscher M, Wagner R, Überla K, Steininger P; CoVaKo Study Group. Prelog M, et al. Among authors: rubio acero r. J Clin Virol. 2024 Feb;170:105622. doi: 10.1016/j.jcv.2023.105622. Epub 2023 Nov 28. J Clin Virol. 2024. PMID: 38091664
24 results